Dataset Information


Menin-MLL inhibitors block oncogenic transformation by MLL fusion proteins in a fusion partner independent manner

ABSTRACT: Chromosomal rearrangements of the Mixed Lineage Leukemia (MLL) gene result in fusion proteins which retain the N-terminal portion of MLL fused with one of more than 70 different fusion partners. The high diversity of MLL fusion partners raises a question whether it is possible to develop a general therapeutic strategy to block the oncogenic activity of MLL fusion proteins in a fusion partner independent manner. We have demonstrated that blocking the menin-MLL interaction using small molecule inhibitor inhibits oncogenic activity of different MLL fusion proteins according to a mechanism that is independent on the fusion partner. Overall design: MLL-AF9, MLL-AF6 and MLL-AF1P transformed cells were treated with the menin-MLL inhibitor MI-2-2

INSTRUMENT(S): Illumina HiSeq 2000 (Mus musculus)

SUBMITTER: Jingya Wang  

PROVIDER: GSE69740 | GEO | 2018-06-09


Similar Datasets

| GSE95511 | GEO
2018-05-25 | PXD009338 | Pride
| GSE103947 | GEO
2016-07-07 | E-GEOD-73457 | ArrayExpress
| GSE60673 | GEO
| GSE110521 | GEO
2011-04-21 | E-GEOD-19577 | ArrayExpress
2011-04-21 | GSE19577 | GEO
| GSE84116 | GEO
2013-04-03 | E-GEOD-43063 | ArrayExpress